Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable 10-67 (IGLV10-67)
- Target
- IGLV10-67
- Molecular classification
- Other (Immunoglobulin gene segment pseudogene)
01
Overview
Immunoglobulin lambda variable 10-67 (IGLV10-67) is classified as a pseudogene within the human genome. Pseudogenes are sequences that resemble functional genes but, due to mutations or deletions, no longer encode active proteins. IGLV10-67, specifically, is an immunoglobulin lambda variable segment that has lost its capacity to undergo normal rearrangement or expression and thus does not contribute to antibody diversity or immune function. It is not considered a therapeutic target and has no established biological function, disease associations, or utility in drug development[4].
02
Mechanism of action
None applicable.
03
Biological functions
None (as a pseudogene, it does not encode an active protein nor does it participate in immune response or other cellular functions[4].)
04
Disease associations
None established (pseudogenes are typically not implicated directly in diseases; no disease associations are listed[4].)
05
Safety considerations
None relevant.
06
Interacting drugs
None (there are no drugs known to interact with IGLV10-67, as it is inactive[4].)
07
Biomarkers
None known.
Beyond the preview
Go deeper on Immunoglobulin lambda variable 10-67 (IGLV10-67).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunoglobulin lambda variable 10-67 (IGLV10-67).